COVID-19 vaccine development and a potential nanomaterial path forward
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccine development and a potential nanomaterial path forward
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 15, Issue 8, Pages 646-655
Publisher
Springer Science and Business Media LLC
Online
2020-07-15
DOI
10.1038/s41565-020-0737-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epitopes for a 2019-nCoV vaccine
- (2020) Guglielmo Lucchese Cellular & Molecular Immunology
- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- The 2019‐new coronavirus epidemic: Evidence for virus evolution
- (2020) Domenico Benvenuto et al. JOURNAL OF MEDICAL VIROLOGY
- Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV
- (2020) Vargab Baruah et al. JOURNAL OF MEDICAL VIROLOGY
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
- (2020) Wenjun Wang et al. Nature Nanotechnology
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature
- (2020) Irnela Bajrovic et al. Science Advances
- Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
- (2020) Michael Lim et al. Pharmaceutics
- A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability
- (2020) Jhanvi Sharma et al. ACS Applied Materials & Interfaces
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- (2020) Alba Grifoni et al. Cell Host & Microbe
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
- (2020) Kenji Mizumoto et al. Eurosurveillance
- Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
- (2020) Sergio Rosales-Mendoza EXPERT OPINION ON BIOLOGICAL THERAPY
- Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
- (2020) Tran Thi Nhu Thao et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
- (2020) Desmond Sutton et al. NEW ENGLAND JOURNAL OF MEDICINE
- News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
- (2020) Lynne Peeples PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Covid-19: four fifths of cases are asymptomatic, China figures indicate
- (2020) Michael Day BMJ-British Medical Journal
- Developing a low-cost and accessible COVID-19 vaccine for global health
- (2020) Peter J. Hotez et al. PLoS Neglected Tropical Diseases
- From SARS to MERS, Thrusting Coronaviruses into the Spotlight
- (2019) Zhiqi Song et al. Viruses-Basel
- A review on microfabrication of thermoplastic polymer-based microneedle arrays
- (2019) Herwig Juster et al. POLYMER ENGINEERING AND SCIENCE
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Current state-of-the-art in plant-based antibody production systems
- (2019) Marcello Donini et al. BIOTECHNOLOGY LETTERS
- Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine
- (2019) Hui Cai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Rational vaccinology with spherical nucleic acids
- (2019) Shuya Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Design and fabrication of a low-cost pilot-scale melt-processing system
- (2019) David M. Wirth et al. POLYMER
- In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma
- (2018) Abner A. Murray et al. MOLECULAR PHARMACEUTICS
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue
- (2018) Karl D. Brune et al. Frontiers in Immunology
- Trial watch: peptide-based vaccines in anticancer therapy
- (2018) Lucillia Bezu et al. OncoImmunology
- Vaccination in the elderly: The challenge of immune changes with aging
- (2018) Annalisa Ciabattini et al. SEMINARS IN IMMUNOLOGY
- Mechanism of action of mRNA-based vaccines
- (2017) Carlo Iavarone et al. Expert Review of Vaccines
- Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
- (2017) Wen-Hsiang Chen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine
- (2017) Zhida Liu et al. Cell Discovery
- Stability of plant virus-based nanocarriers in gastrointestinal fluids
- (2017) Alberto Berardi et al. Nanoscale
- Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
- (2016) Somen Nandi et al. mAbs
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Generation of influenza A viruses as live but replication-incompetent virus vaccines
- (2016) L. Si et al. SCIENCE
- Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries
- (2016) Debra D. Kristensen et al. VACCINE
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Pre-existing immunity against Ad vectors
- (2014) Hugues Fausther-Bovendo et al. Human Vaccines & Immunotherapeutics
- Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
- (2013) Dustin P. Patterson et al. ACS Nano
- Dissolvable Microneedle Arrays for Intradermal Delivery of Biologics: Fabrication and Application
- (2013) Bekir Bediz et al. PHARMACEUTICAL RESEARCH
- Overview of Plant-Made Vaccine Antigens against Malaria
- (2012) Marina Clemente et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Artificial Molecular Clamp: A Novel Device for Synthetic Polymerases
- (2011) Yoshinori Takashima et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
- (2010) Emily M. Plummer et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started